Despite major advances in the inflammatory bowel disease (IBD) treatment landscape, the management of ulcerative colitis (UC) and Crohn’s disease (CD)…

This symposium provided an opportunity for global experts to discuss the challenges posed by the introduction of biosimilars. The impact of the…

Ulcerative colitis (UC) carries a significant, progressive disease burden that is often underestimated or misinterpreted by healthcare providers.

The importance of the gut microbiota to health is becoming more widely appreciated. The range of commensal microorganisms in healthy individuals and in…

Pancreatic cystic neoplasms (PCNs) are no longer considered as rare entities because their prevalence in the general population ranges from 3–20%.

Acute diverticulitis is an acute inflammation of colonic diverticulae that is associated with an episode of severe, prolonged, lower abdominal pain…

Helicobacter pylori treatment is becoming a challenge in light of increasing antimicrobial resistance and falling eradication rates. This is a cause for…

Endoscopic retrograde cholangiopancreatography has become an effective and safe therapeutic method, with clinical success of more than 80%

Advances in medical and surgical therapy mean that significant numbers of children with previously fatal liver disease are surviving into adult life.

Hepatitis E virus (HEV) is a single-stranded, non-enveloped, positive-stranded RNA virus that can be classified into four genotypes with distinct…